Journal article
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?
AG Märtson, MGG Sturkenboom, J Stojanova, D Cattaneo, W Hope, D Marriott, AE Patanwala, CA Peloquin, SG Wicha, TS van der Werf, T Tängdén, JA Roberts, MN Neely, JWC Alffenaar
Clinical Microbiology and Infection | Published : 2020
Abstract
Background: Therapeutic drug monitoring (TDM) is a tool to personalize and optimize dosing by measuring the drug concentration and subsequently adjusting the dose to reach a target concentration or exposure. The evidence to support TDM is however often ranked as expert opinion. Limitations in study design and sample size have hampered definitive conclusions of the potential added value of TDM. Objectives: We aim to give expert opinion and discuss the main points and limitations of available data from antibiotic TDM trials and emphasize key elements for consideration in design of future clinical studies to quantify the benefits of TDM. Sources: The sources were peer-reviewed publications, gui..
View full abstractGrants
Awarded by H2020 Marie Skłodowska-Curie Actions